RE: RE: RE: news! With Bioniche trading at 23 cents, and having been under $1.00 and sliding for two years, is there any question that the whole is worth anywhere near the sum of the parts? Not in my opinion.
Management have been hinting at valuations in animal health for some time, with the implication being that the AH component alone, forget the rest of the company, is grossly undervalued relative to peers. We should have all clued in then. AH wasn't being independently valued for fire and theft insurance, it was being appraised for sale.
I am not sure why shareholders of the 23 stock are upset. There are 3 buyers at the auction, with heavyweight representation to broker the sell side. What other option is there at the moment?
Sell AH and let's partner or sell HH!
Great News!